Melissa Wasserstein

7.4k total citations
93 papers, 3.3k citations indexed

About

Melissa Wasserstein is a scholar working on Physiology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Melissa Wasserstein has authored 93 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Physiology, 33 papers in Molecular Biology and 25 papers in Clinical Biochemistry. Recurrent topics in Melissa Wasserstein's work include Lysosomal Storage Disorders Research (49 papers), Metabolism and Genetic Disorders (25 papers) and Genomics and Rare Diseases (15 papers). Melissa Wasserstein is often cited by papers focused on Lysosomal Storage Disorders Research (49 papers), Metabolism and Genetic Disorders (25 papers) and Genomics and Rare Diseases (15 papers). Melissa Wasserstein collaborates with scholars based in United States, France and United Kingdom. Melissa Wasserstein's co-authors include Margaret M. McGovern, Robert J. Desnick, Edward H. Schuchman, George A. Díaz, Scott E. Brodie, Alan M. Aron, Calogera M. Simonaro, Gerald F. Cox, Roberto Giugliani and David S. Mendelson and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Melissa Wasserstein

90 papers receiving 3.2k citations

Peers

Countries citing papers authored by Melissa Wasserstein

Since Specialization

Citations

This map shows the geographic impact of Melissa Wasserstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Wasserstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Wasserstein more than expected).

Fields of papers citing papers by Melissa Wasserstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Wasserstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Wasserstein. The network helps show where Melissa Wasserstein may publish in the future.

Co-authorship network of co-authors of Melissa Wasserstein

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Wasserstein. A scholar is included among the top collaborators of Melissa Wasserstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Wasserstein. Melissa Wasserstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The motivation and process for developing a consortium‐wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care 2023 ·Clinical and Translational Science ·(unknown), (unknown), (unknown), Jeannette T. Bensen, (unknown), Candice R. Finnila, Lucia A. Hindorff, (unknown), Frances L. Lynch, (unknown), Hadley Stevens Smith, Melissa Wasserstein, Kristen Hassmiller Lich	0
2	When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective 2023 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·Melissa A. Parisi, Michele Caggana, Jennifer L. Cohen, Nina B. Gold, Jill A. Morris, Joseph J. Orsini, Tiina K. Urv, Melissa Wasserstein	8
3	Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults 2023 ·Orphanet Journal of Rare Diseases ·Robin Lachmann, George A. Díaz, Melissa Wasserstein, Nicole M. Armstrong, (unknown), Yong Kim, (unknown)	10
4	Whole‐genome sequencing holds the key to the success of gene‐targeted therapies 2022 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·Jerry Vockley, Annemieke Aartsma‐Rus, Jennifer L. Cohen, Lex M. Cowsert, R. Rodney Howell, Timothy W. Yu, Melissa Wasserstein, Thomas Defay	10
5	Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders 2022 ·International Journal of Neonatal Screening ·(unknown), (unknown), (unknown), Aaron J. Goldenberg, Ellen J. Silver, Melissa Wasserstein	9
6	Hope versus reality: Parent expectations of genomic testing 2021 ·Patient Education and Counseling ·(unknown), Siobhan M. Dolan, Dana Watnick, Katie M. Gallagher, Jacqueline A. Odgis, Sabrina A. Suckiel, (unknown), Bruce D. Gelb, Eimear E. Kenny, Melissa Wasserstein, Carol R. Horowitz, Laurie J. Bauman	15
7	Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency 2021 ·Molecular Genetics and Metabolism Reports ·(unknown), Wenyue Zhang, Chunli Yu, Melissa Wasserstein	24
8	“Is that something that should concern me?”: a qualitative exploration of parent understanding of their child’s genomic test results 2021 ·SHILAP Revista de lepidopterología ·Dana Watnick, Jacqueline A. Odgis, Sabrina A. Suckiel, Katie M. Gallagher, (unknown), (unknown), Bruce D. Gelb, Eimear E. Kenny, Melissa Wasserstein, Carol R. Horowitz, Siobhan M. Dolan, Laurie J. Bauman	7
9	Newborn screening for X-linked adrenoleukodystrophy in New York State: Diagnostic protocol, surveillance protocol and treatment guidelines 2015 ·Molecular Genetics and Metabolism ·Beth Vogel, (unknown), Darius J. Adams, Kristin D׳Aco, Richard W. Erbe, Chin-To Fong, Alejandro Iglesias, David Kronn, Pierre Lévy, Mark L. Morrissey, Joseph J. Orsini, (unknown), Joan E. Pellegrino, Carlos A. Saavedra‐Matiz, Natasha Shur, Melissa Wasserstein, Gerald V. Raymond, Michele Caggana	84
10	Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency 2015 ·Molecular Genetics and Metabolism ·Melissa Wasserstein, Simon Jones, Handrean Soran, George A. Díaz, Natalie Lippa, Beth L. Thurberg, Kerry Culm-Merdek, (unknown), Haig Inguilizian, Gerald F. Cox, Ana Cristina Puga	70
11	Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann–Pick disease type B (acid sphingomyelinase deficiency) 2015 ·Genetics in Medicine ·Margaret M. McGovern, Melissa Wasserstein, Brian Kirmse, W. Lane Duvall, Thomas D. Schiano, Beth L. Thurberg, Susan Richards, Gerald F. Cox	46
12	Motivations, concerns and preferences of personal genome sequencing research participants: Baseline findings from the HealthSeq project 2015 ·European Journal of Human Genetics ·Saskia C. Sanderson, Michael D. Linderman, Sabrina A. Suckiel, George A. Díaz, Randi E. Zinberg, Kadija Ferryman, Melissa Wasserstein, Andrew Kasarskis, Eric E. Schadt	90
13	Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial 2014 ·The Lancet ·Nicola Longo, Cary O. Harding, Barbara K. Burton, Dorothy K. Grange, Jerry Vockley, Melissa Wasserstein, Gregory M. Rice, Alejandro Dorenbaum, Jutta K. Neuenburg, Donald G. Musson, (unknown), Saba Sile	126
14	Types A and B Niemann-Pick disease 2014 ·Best Practice & Research Clinical Endocrinology & Metabolism ·Edward H. Schuchman, Melissa Wasserstein	70
15	Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type 2013 ·Molecular Genetics and Metabolism ·James D. Weisfeld‐Adams, H. Allison Bender, (unknown), Tamiesha Frempong, (unknown), Keyur Patel, Thomas P. Naidich, (unknown), (unknown), (unknown), Melissa Wasserstein, Inga Peter, Yitzchak Frank, George A. Díaz	66
16	Aggressive therapy improves cirrhosis in glycogen storage disease type IX 2013 ·Molecular Genetics and Metabolism ·(unknown), (unknown), Sara D. Siegel, (unknown), (unknown), Melissa Wasserstein, David A. Weinstein	48
17	Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria 2008 ·American Journal of Medical Genetics Part A ·Phillip Lee, Eileen P. Treacy, Eric Crombez, Melissa Wasserstein, Lewis Waber, Jon A. Wolff, U. Wendel, Alex Dorenbaum, Judith D. Bebchuk, Heidi Christ‐Schmidt, Margretta R. Seashore, Marcello Giovannini, Barbara K. Burton, Andrew A. M. Morris	79
18	Cerebral glucose metabolism in adults with early treated classic phenylketonuria 2005 ·Molecular Genetics and Metabolism ·Melissa Wasserstein, Selma E. Snyderman, Claude Sansaricq, Monte S. Buchsbaum	36
19	The Demographics and Distribution of Type B Niemann-Pick Disease: Novel Mutations Lead to New Genotype/Phenotype Correlations 2002 ·The American Journal of Human Genetics ·Calogera M. Simonaro, Robert J. Desnick, Margaret M. McGovern, Melissa Wasserstein, Edward H. Schuchman	102
20	Maple Syrup Urine Disease: Identification and Carrier-Frequency Determination of a Novel Founder Mutation in the Ashkenazi Jewish Population 2001 ·The American Journal of Human Genetics ·Lisa Edelmann, Melissa Wasserstein, Ruth Kornreich, Claude Sansaricq, Selma E. Snyderman, George A. Díaz	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact